Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Cyclooxygenase Inhibitors. Found 5 abstracts

Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Badawi AF, Badr MZ. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review). Int J Oncol. 2002 Jun;20(6):1109-22.
Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer letters. 2002 Oct 08;184(1):7-12.
Clapper ML, Chang WC, Meropol NJ. Chemoprevention of colorectal cancer. Curr Opin Oncol. 2001 Jul;13(4):307-13.
Yang WL, Frucht H. Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis. 2001 Sep;22(9):1379-83.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Cyclooxygenase Inhibitors

Cyclooxygenase Inhibitors Prostaglandin-Endoperoxide Synthase Isoenzymes Female Human antagonists & inhibitors Cytoplasmic and Nuclear Receptors therapeutic use US Gov't Support-PHS Transcription Factors Sprague-Dawley Rats physiology Apoptosis Drug Synergism Rats Anticarcinogenic Agents prevention & control Cell Division Sulfonamides Methylnitrosourea Non-Steroidal Anti-Inflammatory Agents Experimental Mammary Neoplasms enzymology Non-US Gov't Support metabolism 0 (15-deoxyprostaglandin J2) DNA Fragmentation en [Enzymology] 0 (Anticarcinogenic Agents) chemically induced Prostaglandins Diet Therapy Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) prevention & ag [Agonists] Enzyme-Linked Immunosorbent Assay genetics Fluorenes Drug Dose-Response Relationship biosynthesis 169590-42-5 (celecoxib) Vitamins drug effects cytology HT29 Cells 363-24-6 (Dinoprostone) 0 (Cyclooxygenase Inhibitors) pharmacology Prostaglandin D2 Unsaturated Fatty Acids Animal 0 (Isoenzymes) ci [Chemically Induced] 0 (Transcription Factors) me [Metabolism] cdc Genes Chemoprevention ad [Administration & Dosage] 684-93-5 (Methylnitrosourea) Colorectal Neoplasms US Gov't Support-Non-PHS agonists Antineoplastic Agents EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Thiazoles pd [Pharmacology] 61-90-5 (Leucine) de [Drug Effects] Down-Regulation Dietary Fats Tretinoin toxicity aa [Analogs & Derivatives] Breast Neoplasms EC 1-14-99-1 (cyclooxygenase 2) Leucine drug therapy pathology ph [Physiology] administration & dosage Carcinogens pc [Prevention & Control] 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Unsaturated Dietary Fats 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) 0 (Fluorenes) ai [Antagonists & Inhibitors] control bi [Biosynthesis] Dinoprostone Cell Cycle
Last updated on Monday, May 04, 2020